See the DrugPatentWatch profile for invega
The cost of Invega injection can vary significantly based on factors such as dosage, quantity, insurance coverage, and pharmacy. Without insurance, a single 3-month injection of Invega Sustenna (paliperidone palmitate) can range from approximately $3,000 to $5,000 or more [1]. Invega Trinza, a 6-month injection, can cost upwards of $6,000 to $10,000 or more per dose without insurance [1].
What influences the price of Invega injections?
Several elements contribute to the final cost of Invega injections. These include the specific formulation and strength of the medication, the number of doses purchased at once, and the dispensing fees charged by the pharmacy. Geographic location can also play a role in pricing differences between pharmacies [1].
How does insurance affect Invega injection costs?
Insurance plans can substantially reduce the out-of-pocket expense for Invega injections. However, coverage details, including copays, deductibles, and coinsurance, vary widely among different insurance providers and individual plans. Patients may need to meet certain criteria or obtain prior authorization for the medication to be covered [1].
Are there patient assistance programs for Invega?
Manufacturers sometimes offer patient assistance programs or savings cards that can help eligible individuals lower their prescription costs. These programs often have specific income and insurance requirements. Information about such programs can typically be found on the drug manufacturer's website or by inquiring with a healthcare provider or pharmacist [1].
How does Invega injection compare to oral Invega?
Invega is also available in oral tablet form. While oral medications are generally taken daily, Invega injections offer extended-release formulations that are administered less frequently, such as monthly, every three months (Invega Sustenna), or every six months (Invega Trinza) [1]. The cost structures for oral and injectable forms will differ, with injections typically having a higher per-dose price but potentially lower overall annual costs due to infrequent administration.
When do patents for Invega expire?
Patents for medications like Invega are crucial for determining when generic versions can enter the market, which often leads to lower prices. Patent information for Invega and its formulations can be found through resources like DrugPatentWatch.com [2]. The expiration of primary patents can allow for the development and approval of generic paliperidone palmitate injections.